You just read:

MEI Pharma and Kyowa Kirin Announces ME-401 Phase 1b Study to be Highlighted in a Presentation at the Virtual Edition of the 25th European Hematology Association Annual Congress

News provided by

MEI Pharma, Inc.

May 14, 2020, 10:34 ET